RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney

Kidney International
Sébastien SachetelliJohn S D Chan

Abstract

Angiotensinogen (ANG) is the sole substrate of the renin-angiotensin system (RAS). Clinical studies have shown that RAS activation may lead to hypertension, a major cardiovascular and renal risk factor. To delineate the underlying mechanisms of hypertension-induced nephropathy, we generated transgenic mice that overexpress rat ANG (rANG) in the kidney to establish whether intrarenal RAS activation alone can evoke hypertension and kidney damage and whether RAS blockade can reverse these effects. Transgenic mice overexpressing renal rANG were generated by employing the kidney-specific, androgen-regulated protein promoter linked to rANG cDNA. This promoter targets rANG cDNA to renal proximal tubules and responds to androgen stimulation. Transgenic mice displayed kidney-specific expression of rANG, significantly increased blood pressure (BP) and albuminuria in comparison to non-transgenic littermates. Administration of losartan (an angiotensin II (type 1)-receptor antagonist) or perindopril (an angiotensin-converting enzyme inhibitor) reversed these abnormalities in transgenic animals. Renal injury was evident on examination of the kidneys in transgenic mice, and attenuated by losartan and perindopril treatment. We conclude that th...Continue Reading

References

May 1, 1990·The American Journal of Physiology·G SaccomaniL G Navar
Jun 1, 1988·The American Journal of Physiology·R A GomezR M Carey
Mar 25, 1983·Nucleic Acids Research·U NudelD Yaffe
Apr 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·H OhkuboS Nakanishi
Aug 1, 1997·The American Journal of Physiology·K D MitchellJ J Mullins
Jan 3, 2001·American Journal of Physiology. Renal Physiology·Y Ding, C D Sigmund
Apr 19, 2002·Journal of the American Society of Nephrology : JASN·János Peti-PeterdiP Darwin Bell
Oct 12, 2002·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Delphine BertramMing Lo
Mar 26, 2003·Hypertension·Carl Erik MogensenUNKNOWN Preterax in Albuminuria Regression (PREMIER) Study Group
Apr 13, 2004·American Journal of Physiology. Renal Physiology·Julie L LavoieCurt D Sigmund
Oct 16, 2004·BMJ : British Medical Journal·Catherine M ClaseBryce A Kiberd

❮ Previous
Next ❯

Citations

Apr 17, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Michael Bader, Detlev Ganten
May 21, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Romer A Gonzalez-VillalobosKenneth E Bernstein
Dec 17, 2008·Pflügers Archiv : European journal of physiology·Isabelle RuberaFriedrich Beermann
Aug 25, 2012·Pflügers Archiv : European journal of physiology·Hiroyuki Kobori, Maki Urushihara
Apr 28, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Yun-Wen ChenShao-Ling Zhang
Dec 10, 2008·Nature Clinical Practice. Nephrology·Juan Carlos Q Velez
Oct 23, 2010·The Journal of Biological Chemistry·Marcus PohlFranziska Theilig
Aug 2, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Kevin D Burns, Swapnil Hiremath
Feb 4, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ryousuke SatouHiroyuki Kobori
Oct 8, 2009·Journal of Hypertension·Amy MilstedMonte E Turner
Apr 9, 2010·Journal of Hypertension·Hiroyuki KoboriLuis Gabriel Navar
Feb 25, 2011·Journal of Hypertension·Dinko SusicL Gabriel Navar
Sep 27, 2012·Current Opinion in Nephrology and Hypertension·Nirupama Ramkumar, Donald E Kohan
Aug 14, 2009·Clinical and Experimental Pharmacology & Physiology·Naro OhashiHiroyuki Kobori
Jan 9, 2010·Annual Review of Pharmacology and Toxicology·Michael Bader
Jul 15, 2011·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Huiping LiCurt D Sigmund
Nov 4, 2011·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Curt D Sigmund
Jun 27, 2008·American Journal of Physiology. Renal Physiology·Romer A Gonzalez-VillalobosL G Navar
May 14, 2010·American Journal of Physiology. Renal Physiology·Jonathan A CohenMark C Chappell
Jul 20, 2007·American Journal of Physiology. Renal Physiology·Hiroyuki KoboriL Gabriel Navar
Feb 13, 2009·American Journal of Physiology. Renal Physiology·Licy L YanesJane F Reckelhoff
Feb 18, 2010·American Journal of Nephrology·Maki UrushiharaHiroyuki Kobori
Feb 2, 2011·Hypertension·L Gabriel NavarRomer A Gonzalez-Villalobos
Apr 27, 2013·The Journal of Clinical Investigation·Romer A Gonzalez-VillalobosAlicia A McDonough
Jul 19, 2014·PloS One·Alejandra DroguettSergio Mezzano
May 14, 2009·PLoS Pathogens·Jilin ChengClyde S Crumpacker
Dec 7, 2007·Journal of the American Society of Nephrology : JASN·Fang LiuJohn S D Chan
Feb 29, 2008·Journal of the American Society of Nephrology : JASN·Stella TranShao-Ling Zhang
Dec 1, 2010·Journal of the American Society of Nephrology : JASN·Romer A Gonzalez-VillalobosL Gabriel Navar
Aug 24, 2011·International Journal of Nephrology·Maki Urushihara, Shoji Kagami
Jan 1, 2014·Current Opinion in Nephrology and Hypertension·Kenneth E BernsteinRomer A Gonzalez-Villalobos
Aug 7, 2014·Current Hypertension Reports·Jorge F GianiRomer A Gonzalez-Villalobos
Jun 2, 2011·The American Journal of the Medical Sciences·Eros Balam-OrtizGerardo Jimenez-Sanchez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.